The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Newsflash for the Snoozers - Part 5

Tuesday, 1st September 2015 10:16 - by Moosh

Cyprotex (TIDM: CRX)

 

CRX recently entertained the market with a meaty set of interim results (18 August 2015) including the following highlights:

 

-          103 new customers in H1 2015 (of 1100+ customers)

 

-          Expansion of CRX brand into Asia (including several Japanese projects)

 

-          Larger customers signed for long term exclusive service contracts

 

-          Completion and expansion of 2 large US Environmental Protection Agency contracts

 

-          H1 revenues up 28%

 

-          Creation of a Biosciences division

 

-          Growth on track to continue, also benefitting from a usual increased trading activity during H2

 

 

Software Radio Technology (TIDM: SRT)

 

SRT has issued a number of updates to the market which received subdued reactions from long term investors including:

 

-          Rollout of a Middle East tracking project (9 June 2015)

 

-          $700k Philippines Fisheries order (24 July 2015)

 

-          $5m Maritime Domain Management system contract which represents an initial phase of a longer term programme (21 August 2015)

 

The Writer's views are their own, not a representation of London South East's. No advice is inferred or given. If you require financial advice, please seek an Independent Financial Adviser.


Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.